Summary A new machine learning-based hepatic safety score (MHSS) predicts decompensation risk in hepatocellular carcinoma patients, allowing clinicians to personalize systemic therapy and prevent life-threatening liver complications. Transcript INTRO Hey, so I came across this really interesting paper that just dropped in NPJ Digital Medicine, and it's tackling something that's been a real challenge in oncology for a while now—how do we figure out who's actually going to tolerate aggressive cancer therapy versus who's going to run into serious liver complications? Specifically, it's about patients with hepatocellular carcinoma, which is already complicated because, well, they have liver cancer. But here's the thing—a lot of these patients have underlying cirrhosis or […]